Anaphylactoid Reaction to Imiglucerase, but Not to Alglucerase, in a Type I Gaucher Patient
- 30 April 1999
- journal article
- case report
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 25 (2) , 92-94
- https://doi.org/10.1006/bcmd.1999.0231
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enzyme Therapy in Gaucher Disease Type 1: Effect of Neutralizing Antibodies to Acid β-GlucosidaseBlood, 1997
- Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant SourcesAnnals of Internal Medicine, 1995
- Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidaseBlood, 1993
- Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsBlood, 1993
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Immunoglobulin Class and Subclass Distribution of Dextran‐Reactive Antibodies in Human Reactors and Non Reactors to Clinical DextranAllergy, 1982
- Fatal reaction to haemaccelAnaesthesia, 1979
- The SphingolipidosesNew England Journal of Medicine, 1966